POP Biotechnologies, Inc.

About POP Biotechnologies, Inc.

POP Biotechnologies develops platform technologies to address critical needs in oncology and infectious disease through nanotechnology solutions, aiming to advance medical breakthroughs.

Products & Services

POP BIO SNAP Platform:Enables rapid development of highly immunogenic vaccines for infectious diseases.

Chemophototherapy (CPT) with PoP Liposomes:Uses PoP liposomes to deliver targeted chemotherapy drugs to tumors exposed to specific laser light.

SNAP™ Nanoparticle Vaccine Platform

PoP liposome technologies

Chemophototherapy (CPT)

Specialties

Nanotechnology Oncology Infectious Disease Vaccine Development Targeted Chemotherapy Nanotechnology for oncology and infectious diseases Accelerated vaccine development Targeted chemotherapy Immunotherapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 9700000 MR: - FA: up to 9.7 million FAN: 9700000	D: 2026-06-03 FD: 2026-06-03	1 investors
2	RT: Grant T: - FT: Grant	A: 2460000 MR: - FA: $2.46M USD FAN: 2460000	D: 2025-10-01 FD: 2025-10-01	1 investors

Grant Latest

2026-06-03

$9.7M

1 investor (Pro only)

Grant 2025-10-01

$2.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News